Invisalign manufacturer Align Technology reported $1.4 billion in total revenue during the first quarter of 2026. The company released its first quarter financial report April 29. Seven notes from the ...

Align Technology (ALGN) delivered earnings and revenue surprises of +14.41% and +1.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Dental technology company Align Technology (NASDAQ:ALGN) reported Q1 CY2026 results beating Wall Street’s revenue ...

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and ...

Align Technology reported better-than-expected Q1 2026 results, with revenue up 6.2% year-on-year to $1.04 billion and earnings per share beating analyst estimates by nearly 13%. The company, known ...

Align Technology Inc. (ALGN) on Wednesday reported first-quarter profit of $112.8 million. On a per-share basis, the Tempe, Arizona-based company said it had net income of $1.57. Earnings, adjusted ...

Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth The Invisalign® System with mandibular advancement ...

Over 100 Invisalign® and iTero™-trained doctor educators from around the world spent 2 1/2 days immersed in deep-dive education workshops focused on Align’s latest innovations and clinical evidence ...

Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders. With Invisalign First™ aligners and Invisalign® Palatal Expanders ...

Sponsorship reflects commitment to increasing access to care for orthodontic treatment especially for children, and Align’s support of the Canadian orthodontic profession Align Technology, Inc.

The Invisalign System with mandibular advancement featuring occlusal blocks is the latest clinical innovation that expands Align’s Class II treatment portfolio for growing patients by offering ...